Peru Quality System Evidence: BPM, ISO 13485 and CE Documentation for Registration

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

Regulatory information verified as of October 29, 2026

1. Key takeaways

Across the 7 items of Class I, the 8 items of Class II, and the 10 items of Class III/IV in Peru, item 3, the quality system evidence, is the only element whose structure is common to all three classes. It is nevertheless not a matter of submitting any convenient certificate. BPM certification, an ISO 13485 certificate, and a CE mark are three kinds of evidence with entirely different legal characters: BPM rests on a domestic Peruvian normative instrument, ISO 13485 is third-party conformity assessment against a standard, and CE is a market access conclusion of the European Union. CE cannot substitute for the system evidence; it can only serve as corroborating material within the scope it actually covers. Understanding which evidence carries which weight, and against which product category, determines whether item 3 passes on first review or returns as an observation.

2. Legal basis

RegulationNumberPublication dateProvision or key point
Reglamento para el Registro, Control y Vigilancia Sanitaria de Productos Farmacéuticos, Dispositivos Médicos y Productos SanitariosD.S. N° 016-2011-SA2011-07-27Article 124 item 3 and Article 125 item 3 both list quality system type evidence
Manual de Buenas Prácticas de Manufactura para Insumos Médico-Quirúrgicos u Odontológicos Estériles y Productos Sanitarios EstérilesR.M. N° 204-2000-SA/DM2000-06-23The Good Manufacturing Practice, BPM, manual for sterile medical and dental supplies and sterile sanitary products
Reglamento de Establecimientos FarmacéuticosD.S. N° 014-2011-SA2011-07-27Framework for the establishment and sanitary operating authorization of pharmaceutical establishments
Modificatoria del D.S. N° 016-2011-SAD.S. N° 016-2017-SA2017-06-07Amends the technical documentation provisions of Articles 124, 125 and others
Reglamento que establece las Reglas de Clasificación y los Principios Esenciales de Seguridad y DesempeñoD.S. N° 003-2020-SA2020-02-06Classification and Essential Principles framework; system evidence is applied progressively with the class

Regulatory information verified as of October 29, 2026.

3. Expert insights

Insight 1: The three kinds of evidence are generated in different ways, and this determines the boundary of their probative force.

The BPM manual, R.M. N° 204-2000-SA/DM, published on 2000-06-23, is a domestic Peruvian normative instrument addressed to sterile medical and dental supplies and sterile sanitary products, and its assessment criteria are given by the domestic regulator. An ISO 13485 certificate is issued by a third-party certification body against the standard; it demonstrates conformity of the system to the standard but is not itself an act of administrative recognition. A CE mark is a regulatory market access conclusion within the European Union framework; although it contains a system audit component, its conclusion is directed at a specific market. The order of acceptance therefore runs as follows: first, whether a domestic normative requirement corresponds to the declared product category; second, whether the system certificate covers the declared products and the manufacturing address; and only last, whether CE can be added as reinforcing material for an existing conformity conclusion.

Insight 2: CE is a supporting proof, not a replacement.

CE is often presented as the convenient option, but mechanically it is not: the scope of the CE system audit is constrained by the product classification under the European Union framework and may not cover the family to which the declared models belong; if the manufacturing address on the CE certificate differs from the manufacturer address declared in Peru, the evidence fails outright; and CE does not answer the local specific requirements of the domestic BPM manual. The most common outcome of submitting CE as a replacement is a request for supplementary documentation through observations, not direct acceptance.

Insight 3: The three coverage elements, product family, site address, and validity period, form a hard filter.

System evidence almost never fails on the question of whether it exists; it fails on whether it matches. The annex of the certificate must include the declared product family, the site list must include the actual production address, and the certificate must remain valid during both submission and review. For sterile supplies in particular, the requirements of the BPM manual under R.M. N° 204-2000-SA/DM must also be connected to the sterilization process validation evidence; otherwise a gap opens between the system evidence and the product verification evidence that reviewers will ask the applicant to close.

Insight 4: The renewal rhythm of system evidence must be synchronized with the obligations of the holding period.

System certificates carry their own issuance and surveillance audit cycles, while the sanitary registration under D.S. N° 016-2011-SA is valid for 5 years. When the two cycles are not synchronized, a state arises in which the registration is still valid but the system certificate has expired or its scope has narrowed. GRZAN manages the certificate validity dates, the surveillance audit months, and the registration expiry date on a single calendar so that replacement coverage is prepared ahead of any gap.

4. Practical recommendations

  1. Determine the product category first, then the evidence: sterile medical and dental supplies and sterile sanitary products map to the BPM manual scope first.
  2. For all other devices, use the ISO 13485 certificate as the primary evidence and verify the annex product family and site address.
  3. Provide CE as corroborating material alongside, and define its coverage in an accompanying explanation.
  4. Ensure the item 3 evidence aligns completely with the manufacturer information stated in the item 1 sworn declaration.
  5. For certificates nearing expiry, reserve certificate renewal time against the 30 working days deficiency correction window.
  6. The manufacturer site in the system evidence and in verification documents such as sterilization validation must point to the same entity.

5. Verification checklist

□ The primary evidence for item 3 has been selected according to product category, BPM manual scope or ISO 13485

□ The ISO 13485 certificate annex covers the declared product family

□ The certificate site list includes the actual production address and matches the declared manufacturer

□ CE, if provided, has its coverage defined and is not the sole source of system evidence

□ The certificate remains valid through submission and review, with renewal scheduled where expiry is near

□ The system evidence and technical documents such as sterilization validation point to the same manufacturer entity

Regulatory information verified as of October 29, 2026.

*GRZAN Regulatory Team*

GRZAN provides medical device registration support in Peru for manufacturers, importers, and authorized representatives, covering quality system evidence selection, BPM and ISO 13485 alignment, and deficiency response. For inquiries, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail